209 related articles for article (PubMed ID: 20510078)
21. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
22. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
23. Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma-catenin is different in T1 and T2 breast tumours.
Bukholm IR; Nesland JM; Bukholm G
Pathology; 2006 Oct; 38(5):403-7. PubMed ID: 17008277
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.
Li X; Schwartz MR; Ro J; Hamilton CR; Ayala AG; Truong LD; Zhai QJ
Int J Clin Exp Pathol; 2014; 7(5):2551-7. PubMed ID: 24966968
[TBL] [Abstract][Full Text] [Related]
25. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
26. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival.
Paredes J; Correia AL; Ribeiro AS; Milanezi F; Cameselle-Teijeiro J; Schmitt FC
J Clin Pathol; 2008 Jul; 61(7):856-62. PubMed ID: 18381381
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
[TBL] [Abstract][Full Text] [Related]
28. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
Qureshi HS; Linden MD; Divine G; Raju UB
Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
[TBL] [Abstract][Full Text] [Related]
30. Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas.
Castellana B; Escuin D; Pérez-Olabarria M; Vázquez T; Muñoz J; Peiró G; Barnadas A; Lerma E
Hum Pathol; 2012 Nov; 43(11):1902-9. PubMed ID: 22542108
[TBL] [Abstract][Full Text] [Related]
31. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Zhao H; Langerød A; Ji Y; Nowels KW; Nesland JM; Tibshirani R; Bukholm IK; Kåresen R; Botstein D; Børresen-Dale AL; Jeffrey SS
Mol Biol Cell; 2004 Jun; 15(6):2523-36. PubMed ID: 15034139
[TBL] [Abstract][Full Text] [Related]
32. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
33. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
Siitonen SM; Kononen JT; Helin HJ; Rantala IS; Holli KA; Isola JJ
Am J Clin Pathol; 1996 Apr; 105(4):394-402. PubMed ID: 8604681
[TBL] [Abstract][Full Text] [Related]
34. Concomitant loss of p120-catenin and β-catenin membrane expression and oral carcinoma progression with E-cadherin reduction.
Sasaya K; Sudo H; Maeda G; Kawashiri S; Imai K
PLoS One; 2013; 8(8):e69777. PubMed ID: 23936352
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
36. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
Vermeulen JF; van de Ven RA; Ercan C; van der Groep P; van der Wall E; Bult P; Christgen M; Lehmann U; Daniel J; van Diest PJ; Derksen PW
PLoS One; 2012; 7(5):e37864. PubMed ID: 22662240
[TBL] [Abstract][Full Text] [Related]
37. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
[TBL] [Abstract][Full Text] [Related]
38. Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma.
Kim SH; Cha ES; Park CS; Kang BJ; Whang IY; Lee AW; Song BJ; Park J
Jpn J Radiol; 2011 Aug; 29(7):475-82. PubMed ID: 21882089
[TBL] [Abstract][Full Text] [Related]
39. [Invasive lobular carcinoma of basal-like subtype of breast: a clinicopathologic analysis].
Zhang LY; Gao LX; Liu G; Yang GZ; Cheng J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):599-603. PubMed ID: 24314245
[TBL] [Abstract][Full Text] [Related]
40. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]